e-learning
resources
Madrid 2019
Monday, 30.09.2019
Injury and repair: less is more
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC - 2019 - Surfactant protein SP-D to the rescue of NETosis and NET-induced lung surfactant inactivation
R. Arroyo Rodriguez (Madrid, Spain), J. Duerr (Berlin, Germany), M. Khan (Toronto, Canada), M. Echaide (Madrid, Spain), N. Palaniyar (Toronto, Canada), J. Perez-Gil (Madrid, Spain)
Source:
International Congress 2019 – Injury and repair: less is more
Session:
Injury and repair: less is more
Session type:
Oral Presentation
Number:
2118
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Arroyo Rodriguez (Madrid, Spain), J. Duerr (Berlin, Germany), M. Khan (Toronto, Canada), M. Echaide (Madrid, Spain), N. Palaniyar (Toronto, Canada), J. Perez-Gil (Madrid, Spain). LSC - 2019 - Surfactant protein SP-D to the rescue of NETosis and NET-induced lung surfactant inactivation. 2118
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
Surfactant protein expression at various COPD Gold stages
Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury
Related content which might interest you:
Surfactant protein A (SP-A) and alveolar complement activation in patients at-risk for ARDS
Source: Eur Respir J 2002; 20: Suppl. 38, 375s
Year: 2002
LSC - 2018 - Differential effect of ARDS on alveolar macrophage efferocytosis compared to bacterial phagocytosis
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Loss of structural integrity and function of surfactant protein D (SP-D) by cystic fibrosis- related proteases
Source: Eur Respir J 2001; 18: Suppl. 33, 537s
Year: 2001
Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein
Source: Eur Respir J 2008; 32: 405-412
Year: 2008
Surfactant pretreatment preserves lung function in ischemia-reperfusion-injury of the lung
Source: Eur Respir J 2005; 26: Suppl. 49, 221s
Year: 2005
Translocation of TNF-α from the gut to the lung by VILI is reduced by exogenous surfactant therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 375s
Year: 2002
Surfactant protein-A (SP-A) expression in COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 138s
Year: 2007
Recombinant human pulmonary surfactant protein-D (rhSP-D) modulates Th2 responses and suppresses IgE-facilitated allergen binding to B cells
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
Characterization of the activity of the different oligomeric forms of pulmonary human surfactant protein SP-D
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Surfactant protein D is critical for local immunomodulation in the distal lung
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
LSC - 2019 - Neutrophil-derived microvesicles are internalised by lung epithelial cells and induce inflammatory activation
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
LSC - 2019 - RNA degradation is a deficient antiviral mechanism in the asthmatic airway epithelium
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
Neutrophil extracellular traps are pathogenic in ventilator-induced lung injury and its formation is dependent on TLR4 signaling
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Vitamin D-mediated expression of the antimicrobial peptide hCAP18/LL-37 and killing of non-typeable haemophilus influenzae (NTHi) is reduced after 14 days exposure to TNF-α and IL-1β in primary bronchial epithelial cells (PBEC)
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015
Neutrophil extracellular traps promoted alveolar macrophages pyroptosis in LPS induced ALI/ARDS
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Barrier-protective effects of activated protein C in human alveolar epithelial cells
Source: Annual Congress 2013 –Experimental models in critical care
Year: 2013
LSC - 2019 - Sputum protein profiling identifies a key role for neutrophil extracellular traps in exacerbations of bronchiectasis and treatment response
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
LSC - 2019 - Anti-IL5 in mild asthma alters rhinovirus-induced macrophage, B cell and neutrophil responses
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Immunolocalization of surfactant protein-a (SP-A) in the lungs of
pneumocystis
pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept